ANRS, Emerging Infectious Diseases

NCT07081763

Phase 2, Not yet recruiting, 2026, 191 people, 23 Jul 2025, clinicaltrials.gov

NCT06273943

Phase 3, Not yet recruiting, 2024, 322 people, 23 Feb 2024, clinicaltrials.gov

NCT06203132

Phase 3, Recruiting, 2025, 610 people, 12 Jan 2024, clinicaltrials.gov

NCT05403047

Phase 4, Recruiting, 2023, 150 people, 3 Jun 2022, clinicaltrials.gov

NCT04466241

Phase 2/3, Completed, 2020, 294 people, 10 Jul 2020, clinicaltrials.gov

NCT04145258

Phase 3, Recruiting, 2021, 768 people, 30 Oct 2019, clinicaltrials.gov

NCT04022967

Phase 3, Status unknown, 2020, 480 people, 17 Jul 2019, clinicaltrials.gov

NCT03602690

Phase 2, Status unknown, 2018, 54 people, 27 Jul 2018, clinicaltrials.gov

NCT02987530

Phase 3, Completed, 2017, 101 people, 9 Dec 2016, clinicaltrials.gov

NCT02937779

Phase 4, Status unknown, 2017, 933 people, 19 Oct 2016, clinicaltrials.gov

NCT02777229

Phase 3, Completed, 2016, 616 people, 19 May 2016, clinicaltrials.gov

NCT02319200

Collaborator, Phase 3, Terminated, 2015, 11 people, 18 Dec 2014, clinicaltrials.gov

NCT02099604

Phase 3, Withdrawn, 2014, 0 people, 31 Mar 2014, clinicaltrials.gov

NCT01605890

Phase 2, Completed, 2012, 30 people, 25 May 2012, clinicaltrials.gov

NCT01473472

Phase 3, Completed, 2012, 400 people, 17 Nov 2011, clinicaltrials.gov

NCT00918307

Phase 3, Completed, 2009, 248 people, 11 Jun 2009, clinicaltrials.gov